Atea Pharmaceuticals, Inc. - common stock — 현금 흐름 (NASDAQ:AVIR) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 296.73 M-87 M-120.98 M-85.39 M-135.5 M-132.03 M -147.86 M 투자 활동으로 인한 현금 -26 K-4 000-455.41 M40.3 M56.1 M188.79 M 132.92 M 재무활동으로 인한 현금 531.75 M1.47 M370 K257 K267 K-25.75 M -25.14 M 잉여 현금 흐름 296.73 M-87 M-120.98 M-85.39 M-135.5 M-132.03 M -147.86 M

뉴스

Atea Pharmaceuticals - I'm Optimistic Ahead Of Critical HPV Catalyst (NASDAQ:AVIR)

Down 25% in 4 Weeks, Here's Why Atea Pharmaceuticals (AVIR) Looks Ripe for a Turnaround

Atea Pharmaceuticals, Inc. (AVIR) Q1 2026 Earnings Call Transcript

Atea Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:AVIR) 2026-05-12

Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Arcellx (NASDAQ:ACLX), Atea Pharmaceuticals (NASDAQ:AVIR)

Atea Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:AVIR) 2026-03-05

Atea Pharmaceuticals, Inc. (AVIR) Q4 2025 Earnings Call Transcript

Atea, 2026년 4분기 실적 발표: HCV 3상 임상 데이터, 2026년 중반 발표 예정

Atea Q4 2025 slides: pivotal HCV Phase 3 data due mid-2026

Atea Pharmaceuticals, EPS 부진에도 주가 상승

Earnings call transcript: Atea Pharmaceuticals Q4 2025 sees stock rise despite EPS miss

Atea Pharmaceuticals, Inc. (AVIR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:AVIR) 2026-01-19